CME Group Inc. (NASDAQ:CME) Stock Position Decreased by Howe & Rusling Inc.

Howe & Rusling Inc. cut its position in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 1.8% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 34,802 shares of the financial services provider’s stock after selling 626 shares during the quarter. Howe & Rusling Inc.’s holdings in CME Group were worth $7,679,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Capital International Investors lifted its holdings in shares of CME Group by 24.1% in the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after purchasing an additional 3,069,806 shares in the last quarter. PineStone Asset Management Inc. lifted its stake in CME Group by 137.6% in the 2nd quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock worth $444,443,000 after acquiring an additional 1,309,097 shares in the last quarter. Assenagon Asset Management S.A. boosted its position in CME Group by 577.9% during the 2nd quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider’s stock worth $126,872,000 after acquiring an additional 550,133 shares during the period. Ameriprise Financial Inc. increased its holdings in shares of CME Group by 11.3% in the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock valued at $1,038,676,000 after purchasing an additional 537,758 shares during the period. Finally, International Assets Investment Management LLC lifted its position in shares of CME Group by 21,465.5% in the third quarter. International Assets Investment Management LLC now owns 485,871 shares of the financial services provider’s stock worth $1,072,070,000 after purchasing an additional 483,618 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at CME Group

In other news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This represents a 12.01 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Martin J. Gepsman sold 400 shares of CME Group stock in a transaction on Monday, November 4th. The stock was sold at an average price of $222.92, for a total value of $89,168.00. Following the sale, the director now directly owns 25,067 shares of the company’s stock, valued at approximately $5,587,935.64. This trade represents a 1.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 15,621 shares of company stock worth $3,441,063 over the last 90 days. Insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

CME has been the topic of several research reports. Morgan Stanley upped their price objective on shares of CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research note on Thursday, October 17th. Bank of America upped their price target on CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a research note on Thursday, October 3rd. Redburn Atlantic downgraded CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective on the stock. in a research note on Tuesday, October 8th. Piper Sandler upped their target price on CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a research report on Monday, October 28th. Finally, TD Cowen started coverage on shares of CME Group in a research report on Thursday, September 26th. They issued a “hold” rating and a $221.00 price target on the stock. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $224.47.

View Our Latest Stock Analysis on CME

CME Group Trading Up 0.9 %

Shares of CME Group stock opened at $229.66 on Wednesday. The stock has a market capitalization of $82.76 billion, a P/E ratio of 24.15, a price-to-earnings-growth ratio of 5.20 and a beta of 0.55. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $230.74. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. The company has a 50-day simple moving average of $223.02 and a 200 day simple moving average of $210.69.

CME Group (NASDAQ:CMEGet Free Report) last announced its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The company had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same period in the prior year, the business earned $2.25 earnings per share. CME Group’s quarterly revenue was up 18.4% on a year-over-year basis. Research analysts expect that CME Group Inc. will post 10.22 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be paid a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a dividend yield of 2.00%. The ex-dividend date is Monday, December 9th. CME Group’s dividend payout ratio (DPR) is presently 48.37%.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.